Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Nephrol Dial Transplant ( 1997) 12: 1689–1691 Nephrology Dialysis Transplantation Brief Report Central venous catheters for haemodialysis: looking for optimal blood flow G. Jean, C. Chazot, T. Vanel, B. Charra, J. C. Terrat, E. Calemard and G. Laurent Centre de Rein Artificiel de Tassin, Tassin, France Abstract Central venous catheters are commonly used for haemodialysis patients and represent, in our centre, about 15% of the permanent vascular accesses with a total number of more than 230 central venous catheters over the last 10 years. Inadequate blood flow may occur and upsets the nurses, the patients, and the nephrologist. The aim of this study was to identify the factors of the catheter dysfunction. We studied prospectively 25 chronic haemodialysed patients with central venous catheters, 14 women and 11 men, 65±16 ( 55–89 ) years of age, treated with haemodialysis for 6.7±7 (1–26) years. Catheters were tunnelled silicone twin catheters ( Permcath QuintonA n=18, Twincath HemotecA n= 7 ) in right (n=19) and left internal jugular (n=6) inserted by percutaneous Seldinger techniques. We studied the localization of the catheter tip (superior vena cava, right atrium, right ventricular, inferior vena cava), the central venous pressure before and after haemodialysis, the blood pressure ( BP) before and after haemodialysis, the interdialytic weight gain, the number of symptomatic hypotensions during the 10 last dialyses. The patients were divided into two groups: group I with usual adequate catheter function (n=18) and group II with frequent dysfunctions (n=7). Central venous pressure before dialysis was significantly higher in group I with adequate blood flow and the catheter’s tip was more frequently found localized in the right cardiac cavities than in the vena cava. When central venous pressure before dialysis was over 5 mmHg, no dysfunction occurred. Blood pressure was not dierent between the two groups. We found no correlation between central venous pressure and BP, interdialytic weight gain and symptomatic hypotensions. We could not predict the central venous pressure from the mean BP but there was a higher frequency of hypotensions in the hypovolaemic patients. Optimal haemodynamic conditions will be provided by a catheter tip in the right cardiac cavities and a central venous pressure over 5 mmHg which can be provided with vascular filling or dry weight revaluation. Key words: haemodialysis; blood flow; catheter; venous pressure; right atrium Introduction For about 10 years, central venous catheters have been in wide use as temporary or long-term vascular access in haemodialysis [1–3 ]. This frequency is explained by the ageing population and the increasing number of diabetics patients with poor cardiac and vascular conditions, leading to a limited use of native or synthetic arteriovenous fistulas. In case of emergency, catheters are also useful for an immediate dialysis. The main complications of catheters are local or general infections, venous stenosis or thrombosis [4,5]. Inadequate blood flow episodes are certainly the most frequent problem leading to a less ecient haemodialysis delivery. A low blood flow may arise from multiple causes: formation of an intraluminal or periluminal catheter clot which can be treated or prevented by general or local heparinization, daily low-dose warfarin, local thrombolysis, or J-guidewire insertion [6,7]; sometimes the low blood flow is related to the catheter tip position against the atrium or vena cava wall and the catheter can be moved by the radiologists or has to be changed [8,9]. Commonly, a low blood flow problem is treated by the nursing sta initially, and sometimes successfully, by the arterial and venous lumen inversion which may increase access recirculation, the shift of the patient posture, or a syringe catheter aspiration. The aim of this study was to identify some other anatomical or haemodynamical factors that may explain some of the dysfunction episodes resistant to these manoeuvres and not avoided by a general decoagulation. Methods Correspondence and oprint requests to: Guillaume Jean, Centre de Rein Artificiel de Tassin, 42 avenue du 8 mai 1945, 69160 Tassin, France. Central venous catheters represent 15% of the permanent vascular accesses in our centre with a total of over 230 © 1997 European Renal Association–European Dialysis and Transplant Association 1690 catheters used in the last 10 years. We have studied prospectively 25 haemodialysed patients with a double-lumen tunnelled catheter, 14 women and 11 men, 65.6±16 (mean±SD) years old, treated with haemodialysis since 6.8±7. (1–26) years. Nephropathies were: 3 polycystic kidney diseases, 6 diabetes, 4 interstitial nephropathies, 4 glomerular nephropathies, 1 myeloma, 1 amyloidosis, and 6 undetermined. Haemodialysis sessions were performed three time a week with acetate (n=18) or bicarbonate (n=7) buer, for 5 h (n=6 ) or 8 h (n=19) and with 1–1.8 m2 cuprophane membranes. Silicone catheters were tunnelled (18 Permcath QuintonA double-lumen with a dacron cu, and 7 Twincath HemotecA double catheters without cu ), inserted by Seldinger percutaneous technique in the right (n=19) or left (n=6 ) internal jugular vein. Prescription of these catheters had always been due to the deficiency or the absence of arteriovenous native or prosthesis fistulae. Mean survival rate of catheter was 12 months ( 1–52 months). Catheters were heparinized locally with 5000 u/ml heparin and obstruction episodes were treated by local thrombolysis. We have studied the localization of the catheter tip on a chest X-ray: superior or inferior vena cava, right atrium, or ventricle. We measured the central venous pressure through the catheter arterial lumen with a water column before and after the dialysis, after flushing internal blood, and before saline restitution. Systolic and diastolic arterial blood pressures before and after the dialysis treatment, were also recorded. None of the patients was taking antihypertensive medication. These measurements were recorded twice in two successive midweek dialysis sessions. We have recorded the interdialytic weight gain before each session. Averages of the two sessions were taken in account. We also recorded the perdialytic symptomatic hypotension episodes of the 10 last haemodialysis sessions, allowing a representative vision of the haemodynamical stability, dry weight remaining stable. The patients were divided into two groups: group I (n= 18 ) with a catheter allowing the prescribed blood flow ( 220–300 ml/min), and group II (n=7 ), which included the catheters with a regular dysfunction not improved by the local thrombolysis and the use of daily low doses of warfarin or aspirin. We verified that the two groups were homogeneous for the central vein used, the type of catheter, age, sex, buer, daily low dose of warfarin, diabetes, and cardiovascular events. Using the two samples t test, and specially the Mann–Whitney-Wilcoxon non-parametric test because of the small number of patients and the non-Gaussian distribution, we compared the two groups for the studied parameters. We also made a x2 test between group I and II according to the catheter tip localization in right cardiac cavities (atrium and ventricle) or in the vena cava. Results The characteristics of the two groups are shown in Table 1. The only significant dierence is the more frequent use of warfarin in group II related to the more frequent episodes of low blood flow. Mean haematocrit was 32.6%, not dierent between the two groups. No infection occurred during the study period. Results are shown in Table 2: systolic and diastolic arterial BP, before and after dialysis, were not significantly dierent between the two groups but there was a tendency to a systolic and diastolic higher BP in group II with frequent catheter dysfunctions. We found G. Jean et al. Table 1. Comparisons of the two groups for central vein side ( RIJ, right internal jugular in %), TC ( Twincath catheter in %), age in years, diabetes ( DB, %), cardiovascular events (CV, %), sex in % of male, acetate buer (%), patients treated with preventive warfarin ( WF ) in % Group RIJ TC Age DB CV Male sex Acetate WF I II P 78 72 NS 27 28 NS 64.5 66 NS 27 14 NS 83 71 NS 16 71 0.005 22 47 14 41 NS NS no correlation between the level of systolic or diastolic BP and central venous pressure and some patients in group II had higher BP with lower venous pressure than in group II. Hypotension episodes were significantly more frequent in group II (P=0.05), and associated with significantly lower interdialytic weight gain (P<0.005), with slightly higher systolic BP (NS ) and lower initial central venous pressures (P=0.009). Because of haemodynamically unstable bicarbonate selected patients, hypotension was more frequent is this little group (n=7, mean hypotension 2.5±0.9 per 10 dialyses) than in the acetate group (n=18 mean hypotension 0.5±0.2) P<0.05. All but one bicarbonate-buered patient were on 5-h dialyses and all the acetate-buered patients on 8 h. So long acetate session seems to ensure a better haemodynamic stability (P<0.05). In group I, the tip of the catheter was more frequently localized in the right cardiac cavities than in vena cava ( x2 test P=0.05). The localization may aect the measured central venous pressure level. The catheters whose central venous was above 5 mmHg, were seldom associated with dysfunction. Discussion Central venous catheters are increasingly used in chronic haemodialysis patients. Their facility of assemblage, their possible immediate use, the blood flows achieved with a low recirculation rate are qualities counterbalanced by the infectious and thrombosis risks. Eectively in our experience of more than 200 catheters, access recirculation is low. Measured with 30 s low flow, we found mean 3% recirculation in normal, and 4.5% in AV inversion. This will make a very small dierence in urea reduction ratio ( URR mean 79%) or Kt/V (mean 1.9) in 5- or 8-h dialyses. Frequent low blood flows have multiple causes linked to a thrombotic process or a mechanical problem. Among these factors, we have studied the localization of the catheter tip, (vena cava, right atrium, or ventricle), and the central venous blood pressure measured in the catheter. Looking for dry weight and normal blood pressure without antihypertensive medications is among our daily preoccupations and we sometimes maintain some slightly hypertensive patients in relative hypovolaemia, as is seen in group II with low initial central venous Central venous haemodialysis catheters and optimal blood flow 1691 Table 2. Results of mean±SD for central venous pressure before (CVP1) and after (CVP2) dialysis session (mmHg); systolic ( BPs) and diastolic ( BPd) blood pressure (mmHg); interdialytic weight gain (IWG ) ( kg), symptomatic hypotension (SH) episodes per dialysis; catheter tip position in % of intracardiac localization. P=t test non-parametric, except x2 for position. Group CVP1 CVP2 BPs1 BPs2 BPd1 BPd2 IWG SH Position I II P 7.3±1.7 0.6±1 0.009 3.7±0.9 0.1±0.9 0.1 136±7 150±11 ns 115±6 136±10 ns 65±3 82±6 ns 63±3 67±3 ns 1.5±0.2 0.6±0.1 0.005 0.6±0.3 2.4±0.9 0.05 88 57 0.05 Group I (n=28) with good blood flow and group II (n=7 ) with frequent dysfunctions. pressure and a tendency to higher BP. Even if central venous pressure is not a perfect reflection of hydration, predialysis hypovolaemia is possibly related to a nonvolume-dependent hypertension. In addition to predialytic BP recording, the evaluation of the volaemia as measured by symptomatic hypotension may be a factor to take into account in dry-weight determination. Our results confirm the preliminary thoughts that motivated this study: hypovolaemic patients (some patients begin their dialysis with a central venous pressure ∏5−mmHg), have significantly more frequent low blood flow incidents than normovolaemic patients with a positive pressure. A characteristic of these low blood flows is their delayed occurrence after a variable ultrafiltration duration frequently associated with a slight blood-pressure drop. Although that seems very logical, we did not find reported data studying this factor in the literature. The other important factor already reported [8 ] is the position of the catheter tip in the venous system. Our study highlights the importance of placing the tip of the catheter in the right cardiac cavities and ideally in the middle of the right atrium in order to avoid vena cava wall suction worsened by hypovolaemia. Placing the catheter tip in the right ventricle was not a deliberate decision. We found this position in two cases in catheters in place for more than 3 years with an excellent blood flow. No complications occurred but central venous pressure was higher, with a systolic peak. We do not recommend this localization especially in cases needing endoluminal manoeuvre. The type of catheter, Permcath or Twincath, the side of the jugular vein, age, and sex, are not predictive of catheter function. Haemodynamic factors represent only a part of catheter dysfunction causes with regional and local thromboses, kinking, or wall suction phenomena. Hypovolaemia, reflected by low central venous pressure, is one cause of catheter dysfunction in which a simple intervention is possible. Conclusions Optimal haemodynamic conditions of catheter function are achieved by the placement of the catheter tip in right cardiac cavities and the maintenance of an initial central venous pressure above +5 mmHg, that remains in a physiological range. In haemodialysis patients it is easy, using a catheter, to measure central venous pressure. A vascular filling at the dialysis onset or later during symptomatic hypovolaemia may represent a simple treatment for catheter low flow in hypovolaemic patients. References 1. Blake PG, Huraib S, Wu G, Uldall PR. The use of a dual lumen jugular venous catheters as a definitive long term access for hemodialysis. Int J Artif Organs 1990; 13( 1): 26–31 2. Canaud B, Saunier F, Beraud JJ, Joyeux H, Mion C. La canulation jugulaire interne avec deux cathéters silastic. Une nouvelle méthode d’accés vasculaire pour hémodialyse. Néphrologie 1986; 7: 57–61 3. Tesio F, De-Baz H, Panarello G, Quaia P, Raimondi A, Schinella D. Double catheterization of the internal jugular vein for hemodialysis: indications, techniques and clinical results. Artif Organs 1994; 18( 4):301–304 4. Schwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL. Prospective evaluation of a Dacron cued hemodialysis catheter for prolonged use. Am J Kidney Dis 1988; 11( 2): 166–169 5. Shusterman NH, Kloss K, Mullen JL. Successful use of doublelumen, silicone rubber catheters for permanent hemodialysis access. Kidney Int 1989; 35: 887–890 6. Gibson SP, Mosquera D. Five years experience with Quinton Permcath for vascular access. Nephrol Dial Transplant 1991;6: 269–274 7. Shrivastava D, Lundin Ap, Dosunmu B, Rao TKS, Beyer MM, Friedman EA. Salvage of clotted jugular vein hemodialysis catheters. Nephron 1994; 68: 77–79 8. McGonigle DJ, Shrock LG, Hickman RO. Experience using central venous access for long-term hemodialysis. Am J Surg 1983; 145: 571–573 9. Moss AH, McLaughlin MM, Lempert KD, Holley JL. Use of silicone catheter with a Dacron cu for dialysis short-term vascular access. Am J Kidney Dis 1988; 12(6 ): 492–498 Received for publication: 9.1.97 Accepted in revised form: 11. 4.97